Chickenpox Vaccine for At-Risk Groups
Supply of chickenpox vaccine for at-risk groups: The purchase quantity may be reduced by up to 20% per part. A valid marketing authorization for the medicinal product is required, issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products or by the Council of the European Union/European Commission. The validity of the documents must cover the entire contract performance period. Foreign language documents must be submitted with a Polish translation.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 601004-2026HTML
- TED PDF — 601004-2026PDF
- TED XML — 601004-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.
Lots (3)
- LOT-0001Windpockenimpfstoff für Risikogruppen, Teil 1
- LOT-0002Windpockenimpfstoff für Risikogruppen, Teil 2
- LOT-0003Windpockenimpfstoff für Risikogruppen, Teil 3